Livzon Pharmaceutical Group Inc.

Quick facts

Marketed products

• amoxicillin and clarithromycin
• Esoprazole · Other

Phase 3 pipeline

• Ilaprazole tablet · Gastroenterology
  Ilaprazole is a proton pump inhibitor that suppresses gastric acid secretion by irreversibly blocking the H+/K+-ATPase enzyme in gastric parietal cells.
• JP-1366 simulation tablets
  JP-1366 is a simulation tablet formulation designed to evaluate pharmaceutical delivery and bioavailability characteristics in clinical settings.
• LZM012
  LZM012 is an investigational therapeutic agent in phase 3 development by Livzon Pharmaceutical Group, but its specific mechanism of action is not publicly disclosed.
• SARS-Cov-2 Vaccine Inactivated · Immunology
  This vaccine works by introducing inactivated SARS-Cov-2 virus to stimulate an immune response.

Phase 2 pipeline

• H001 Capsule 200mg-bid
• H001 Capsule 200mg-qd · Cardiovascular
  H001 Capsule 200mg-qd is a medication that targets the renin-angiotensin system to lower blood pressure.
• H001 Capsule 300mg-qd

Phase 1 pipeline

• shenqifuzheng · Other
• V-01
• V-01D-351

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Livzon Pharmaceutical Group Inc. portfolio CI brief
• Livzon Pharmaceutical Group Inc. pipeline updates RSS